Literature DB >> 1424285

The putative role of cytokines in the induction of primary anti-phospholipid syndrome in mice.

P Fishman1, R Bakimer, M Blank, D Sredni, M Djaldetti, Y Shoenfeld.   

Abstract

Antiphospholipid syndrome (APLS) is characterized by thrombocytopenia, thromboembolic phenomena and recurrent fetal loss, associated with anti-cardiolipin antibodies (ACA) and/or lupus anticoagulant. The syndrome may be primary or may be associated with other conditions such as systemic lupus erythematosus (SLE). In this study we induced primary APLS following immunization of BALB/c mice with a human monoclonal ACA (H-3). Analysis of the cytokine profile of the mice with experimental APLS indicated low production of IL-2, IL-3 and granulocyte-macrophage colony-stimulating factor (GM-CSF) by concanavalin A (Con A)-stimulated splenocytes of H-3 immunized mice. It seems that the low levels of IL-3 and GM-CSF have a potential role in the fetal loss of the APLS. Whatever the mechanism of IL-3 and GM-CSF in preventing fetal loss, these results may have therapeutic bearing on the reproductive outcome in women and other species with APLS.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1424285      PMCID: PMC1554616          DOI: 10.1111/j.1365-2249.1992.tb07940.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  29 in total

1.  The effect of the immunomodulator agent AS101 on interleukin-2 production in systemic lupus erythematosus (SLE) induced in mice by a pathogenic anti-DNA antibody.

Authors:  M Blank; B Sredni; M Albeck; E Mozes; Y Shoenfeld
Journal:  Clin Exp Immunol       Date:  1990-03       Impact factor: 4.330

2.  Effects of lymphokines and immune complexes on murine placental cell growth in vitro.

Authors:  D T Armstrong; G Chaouat
Journal:  Biol Reprod       Date:  1989-03       Impact factor: 4.285

3.  Defective production of interleukin-1 and tumour necrosis factor-alpha by stimulated monocytes from patients with systemic lupus erythematosus.

Authors:  G Mũzes; C V Vien; R González-Cabello; J Fehér; P Gergely
Journal:  Acta Med Hung       Date:  1989

Review 4.  Antiphospholipid antibodies: more than just a disease marker?

Authors:  C Mackworth-Young
Journal:  Immunol Today       Date:  1990-02

5.  Elevated levels of interleukin-6 in cerebrospinal fluid from patients with systemic lupus erythematosus and central nervous system involvement.

Authors:  S Hirohata; T Miyamoto
Journal:  Arthritis Rheum       Date:  1990-05

6.  Soluble interleukin-2 receptors in systemic lupus erythematosus.

Authors:  R E Wolf; W G Brelsford
Journal:  Arthritis Rheum       Date:  1988-06

Review 7.  Rheumatoid arthritis: an editorial perspective based on cytokine imbalance.

Authors:  N Talal; E Flescher
Journal:  J Autoimmun       Date:  1988-08       Impact factor: 7.094

8.  Monoclonal hybridoma anti-cardiolipin antibodies from SLE mice.

Authors:  K Ichikawa; K Shimada; Y Nawata; T Ishii; H Tomioka; S Yoshida; T Koike
Journal:  Clin Exp Immunol       Date:  1988-10       Impact factor: 4.330

9.  Primary antiphospholipid syndrome.

Authors:  D Alarcón-Segovia; J Sanchez-Guerrero
Journal:  J Rheumatol       Date:  1989-04       Impact factor: 4.666

View more
  8 in total

1.  Preventing antiphospholipid antibody-induced fetal loss: a new idea.

Authors:  M D Lockshin
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

Review 2.  Antiphospholipid antibodies. A marker for thrombosis and recurrent abortion.

Authors:  M A Khamashta; G R Hughes
Journal:  Clin Rev Allergy       Date:  1994

3.  Anti-idiotype immunomodulation of experimental anti-phospholipid syndrome via effect on Th1/Th2 expression.

Authors:  I Krause; M Blank; Y Levi; T Koike; V Barak; Y Shoenfeld
Journal:  Clin Exp Immunol       Date:  1999-07       Impact factor: 4.330

4.  IgG2 subclass restriction of anti-beta 2 glycoprotein 1 antibodies in autoimmune patients.

Authors:  J Arvieux; B Roussel; D Ponard; M G Colomb
Journal:  Clin Exp Immunol       Date:  1994-02       Impact factor: 4.330

5.  Immunization with anti-neutrophil cytoplasmic antibody (ANCA) induces the production of mouse ANCA and perivascular lymphocyte infiltration.

Authors:  M Blank; Y Tomer; M Stein; J Kopolovic; A Wiik; P L Meroni; G Conforti; Y Shoenfeld
Journal:  Clin Exp Immunol       Date:  1995-10       Impact factor: 4.330

Review 6.  Autoimmunity and recurrent pregnancy losses.

Authors:  Ricard Cervera; Juan Balasch
Journal:  Clin Rev Allergy Immunol       Date:  2010-12       Impact factor: 8.667

7.  Significant changes in the levels of secreted cytokines in brains of experimental antiphospholipid syndrome mice.

Authors:  Assaf Menachem; Joab Chapman; Aviva Katzav
Journal:  Autoimmune Dis       Date:  2012-02-22

Review 8.  Revisiting the molecular mechanism of neurological manifestations in antiphospholipid syndrome: beyond vascular damage.

Authors:  M Carecchio; R Cantello; C Comi
Journal:  J Immunol Res       Date:  2014-03-13       Impact factor: 4.818

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.